Granulocyte colony-stimulating factor and other cytokines in antifungal therapy

Clinical Microbiology and Infection

Volumn 7, Issue SUPPL. 2, 2001, Pages 62-67

  Roilides, E ^a   Farmaki, E ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; CYCLOPHOSPHAMIDE; FLUCONAZOLE; FLUCYTOSINE; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; ITRACONAZOLE; POSACONAZOLE; VORICONAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIFUNGAL ACTIVITY; CANDIDIASIS; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENTIATION; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNE RESPONSE; LEUKOCYTE ACTIVATION; MOUSE; MYCOSIS; NEUTROPENIA; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIDE EFFECT;

ANIMALIA;

EID: 0035746820     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2001.tb00011.x     Document Type: Article

References (41)

1. Potential role of colony-stimulating factors in the prevention and treatment of infectious diseases
2. Neutrophil oxidative burst in response to blastoconidia and pseudohyphae of Candida albicans: Augmentation by granulocyte colony-stimulating factor and interferon-γ
3. Enhancement of oxidative response and damage caused by human neutrophils to Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon
4. Granulocyte-colony stimulating factor potentiates anti-Candida albicans growth inhibitory activity of polymorphonuclear cells
5. Effects of granulocyte colony-stimulating factor and interferon-γ on antifungal activity of human polymorphonuclear neutrophils against pseudohyphae of different medically important Candida species
6. Comparison of interferon-gamma, granulocyte colony-stimulating factor, and granulocyte-macrophage colony-stimulating factor for priming leukocyte-mediated hyphal damage of opportunistic fungal pathogens
7. Granulocyte colony-stimulating factor administered in vivo augments neutrophil-mediated activity against opportunistic fungal pathogens
8. Beneficial effect of recombinant human granulocyte colony-stimulating factor on fungicidal activity of polymorphonuclear leukocytes from patients with AIDS
9. Impairment of neutrophil fungicidal activity in HIV-infected children against Aspergillus fumigatus hyphae
10. Prevention of corticosteroid-induced suppression of human polymorphonuclear leukocyte-induced damage of Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and interferon-γ
11. The role of immunor-econstitution in the management of refractory opportunistic fungal infections
12. Recombinant murine granulocyte colony-stimulating factor protects against acute disseminated Candida albicans infection in nonneutropenic mice
13. Protective effect of human granulocyte colony-stimulating factor on Candida infections in normal and immunosuppressed mice
14. Antifungal combination with G-CSF and fluconazole in experimental disseminated candidiasis
15. Granulocyte-colony stimulating factor facilitates the restoration of resistance to opportunistic fungi in leukopenic mice
16. Effects of rhG-CSF on neutropenic mice infected with C. albicans: Acceleration of recovery from neutropenia and potentiation of anti-Candida resistance
17. Effects of granulocyte colony-stimulating factor in experimental hepatosplenic candidiasis in granulocytopenic rabbits
18. Modulation of neutrophil function in host defense against disseminated Candida albicans infection in mice
19. Protective effect of human granulocyte colony-stimulating factor on Cryptococcus and Aspergillus infections in normal and immuno-suppressed mice
20. Granulocyte colony-stimulating factor and azole antifungal therapy in murine aspergillosis: Role of immune suppression
21. Effects of granulocyte and granulocyte-macrophage colony-stimulating factors in a neutropenic murine model of trichosporonosis
22. Successful treatment of invasive aspergillosis in chronic granulomatous disease by bone marrow transplantation, granulocyte colony-stimulating factor-mobilized granulocytes, and liposomal amphotericin-B
23. Successful treatment of a Trichosporon beigelii septicemia in a granulocytopenic patient with amphotericin B and granulocyte colony-stimulating factor
24. Successful treatment of disseminated zygomycosis in a neutropenic patient with amphotericin B lipid complex and granulocyte colony-stimulating factor
25. Role of granulocyte colony-stimulating factor in the management of infection with Fusarium oxysporum in a neutropenic child
26. Successful treatment of invasive thoracopulmonary mucormycisis in a patient with acute lymphoblastic leukemia
27. Role of granulocyte colony-stimulating factor in the treatment of mucormycosis
28. Treatment of invasive pulmonary aspergillosis in severely neutropenic children with malignant disorders using liposomal amphotericin B, granulocyte colony-stimulating factor and surgery: Report of 5 cases
29. Multiple fungal brain abscesses in a child with acute myeloblastic leukemia
30. Results of a randomized trial of granulocyte colony-stimulating factor in patients with infection and severe granulocytopenia
31. A randomized, double-blind, placebo-controlled, phase III study of Filgrastin in remission induction and consolidation therapy for adults with de novo acute myeloid leukemia
32. A double-blind, randomized, placebo-controlled phase II study of filgrastim (recombinant granulocyte colony-stimulating factor) in combination with fluconazole for treatment of invasive candidiasis and patients
33. Activity of voriconazole combined with neutrophils or monocytes against Aspergillus fumigatus: Effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor
34. Activity of voriconazole, a new triazole, combined with neutrophils or monocytes against Candida albicans: Effect of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor
35. Effect of granulocyte-macrophage colony-stimulating factor on candidacidal activity of neutrophils, monocytes or monocyte-derived macrophages and synergy with fluconazole
36. Effect of granulocyte colony-stimulating factor on the candidacidal activity of polymorphonuclear neutrophils and their collaboration with fluconazole
37. Comparison of neutrophil and monocyte function by microbicidal cell-kill assay in patients with cancer receiving granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, or no cytokine chemotherapy
38. Antifungal effects of yeast-derived rhu-GM-CSF in patients receiving high-dose chemotherapy given with or without autologous stem cell transplantation: A retrospective analysis
39. Treatment of neutropenia-related fungal infections with granulocyte colony-stimulating factor-elicited white blood cell transfusions: A pilot study
40. Defective antifungal activity of monocyte-derived macrophages from HIV-infected children against Aspergillus fumigatus
41. Modulation of neutrophil-mediated activity against the pseudohyphal form of Candida albicans by granulocyte colony-stimulating factor (G-CSF) administered in vivo